Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.

Machado RF, Anthi A, Steinberg MH, Bonds D, Sachdev V, Kato GJ, Taveira-DaSilva AM, Ballas SK, Blackwelder W, Xu X, Hunter L, Barton B, Waclawiw M, Castro O, Gladwin MT; MSH Investigators.

JAMA. 2006 Jul 19;296(3):310-8.

PMID:
16849664
2.

Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations.

Voskaridou E, Tsetsos G, Tsoutsias A, Spyropoulou E, Christoulas D, Terpos E.

Haematologica. 2007 Jun;92(6):738-43.

3.

NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease.

Machado RF, Hildesheim M, Mendelsohn L, Remaley AT, Kato GJ, Gladwin MT.

Br J Haematol. 2011 Aug;154(4):512-20. doi: 10.1111/j.1365-2141.2011.08777.x. Epub 2011 Jun 21.

4.

N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.

Mokhtar GM, Adly AA, El Alfy MS, Tawfik LM, Khairy AT.

Hemoglobin. 2010;34(1):78-94. doi: 10.3109/03630260903554621.

PMID:
20113292
5.

Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom.

Gladwin MT, Barst RJ, Gibbs JS, Hildesheim M, Sachdev V, Nouraie M, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli E, Girgis RE, Morris CR, Berman Rosenzweig E, Badesch DB, Lanzkron S, Castro OL, Taylor JG 6th, Goldsmith JC, Kato GJ, Gordeuk VR, Machado RF; walk-PHaSST Investigators and Patients.

PLoS One. 2014 Jul 2;9(7):e99489. doi: 10.1371/journal.pone.0099489. eCollection 2014.

6.

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.

Thakkar V, Stevens WM, Prior D, Moore OA, Byron J, Liew D, Patterson K, Hissaria P, Roddy J, Zochling J, Sahhar J, Nash P, Tymms K, Celermajer D, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Arthritis Res Ther. 2012 Jun 12;14(3):R143. doi: 10.1186/ar3876.

7.

An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.

Klings ES, Machado RF, Barst RJ, Morris CR, Mubarak KK, Gordeuk VR, Kato GJ, Ataga KI, Gibbs JS, Castro O, Rosenzweig EB, Sood N, Hsu L, Wilson KC, Telen MJ, Decastro LM, Krishnamurti L, Steinberg MH, Badesch DB, Gladwin MT; American Thoracic Society Ad Hoc Committee on Pulmonary Hypertension of Sickle Cell Disease.

Am J Respir Crit Care Med. 2014 Mar 15;189(6):727-40. doi: 10.1164/rccm.201401-0065ST.

8.

The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population.

Zhu Q, Xiao W, Bai Y, Ye P, Luo L, Gao P, Wu H, Bai J.

Clin Interv Aging. 2016 Feb 16;11:245-53. doi: 10.2147/CIA.S98151. eCollection 2016.

9.

Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.

Fijalkowska A, Kurzyna M, Torbicki A, Szewczyk G, Florczyk M, Pruszczyk P, Szturmowicz M.

Chest. 2006 May;129(5):1313-21.

PMID:
16685024
10.

Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP.

N Engl J Med. 2004 Feb 26;350(9):886-95.

11.

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.

Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P.

JAMA. 2005 Apr 6;293(13):1609-16.

PMID:
15811980
12.

Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.

Ordu S, Ozhan H, Alemdar R, Aydin M, Caglar O, Yuksel H, Kandis H.

Tex Heart Inst J. 2012;39(1):30-5.

13.

High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.

Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, Mouthon L, Guillevin L, Meyer O, Ekindjian OG, Weber S, Kahan A.

Arthritis Rheum. 2008 Jan;58(1):284-91. doi: 10.1002/art.23187.

14.

N-terminal pro-brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension.

Leuchte HH, El Nounou M, Tuerpe JC, Hartmann B, Baumgartner RA, Vogeser M, Muehling O, Behr J.

Chest. 2007 Feb;131(2):402-9.

PMID:
17296640
15.

NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in Africa.

Aliyu ZY, Suleiman A, Attah E, Mamman AI, Babadoko A, Nouraie M, Mendelsohn L, Kato GJ, Gordeuk VR, Gladwin MT.

Br J Haematol. 2010 Jul;150(1):102-7. doi: 10.1111/j.1365-2141.2010.08195.x. Epub 2010 Apr 16.

16.

N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.

Stähli BE, Gebhard C, Saleh L, Falk V, Landmesser U, Nietlispach F, Maisano F, Lüscher TF, Maier W, Binder RK.

Catheter Cardiovasc Interv. 2015 Jun;85(7):1240-7. doi: 10.1002/ccd.25788. Epub 2015 Jan 19.

PMID:
25511571
17.

C-reactive protein and NT-proBNP as surrogate markers for pulmonary hypertension in Gaucher disease.

Elstein D, Nir A, Klutstein M, Rudensky B, Zimran A.

Blood Cells Mol Dis. 2005 May-Jun;34(3):201-5.

PMID:
15885602
18.

Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension.

Rhodes CJ, Wharton J, Howard LS, Gibbs JS, Wilkins MR.

Heart. 2011 Jul;97(13):1054-60. doi: 10.1136/hrt.2011.224857. Epub 2011 May 10.

PMID:
21558476
19.

N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study.

Patton KK, Sotoodehnia N, DeFilippi C, Siscovick DS, Gottdiener JS, Kronmal RA.

Heart Rhythm. 2011 Feb;8(2):228-33. doi: 10.1016/j.hrthm.2010.10.038. Epub 2010 Oct 30.

20.

N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency.

Harbaum L, Hennigs JK, Baumann HJ, Lüneburg N, Griesch E, Bokemeyer C, Grünig E, Klose H.

PLoS One. 2014 Apr 21;9(4):e94263. doi: 10.1371/journal.pone.0094263. eCollection 2014.

Supplemental Content

Support Center